To Study of The Cervical Cancer inWomen Between the Age Of 35 To 60YearsandDiscussAboutPapStaining

Background: Materials and Methods: All the uterine cervical biopsies and hysterectomy specimens (for cervical lesions) received in our institution were evaluated retrospectively from January 2022 to August 2023. After standard grossing and processing procedure, the tissues were examined in hematoxyline and eosin stained slides and histopathological evaluation was done and pap staining are also performed. The findings were correlated with age, symptoms, gravida, parity and other relevant clinical details wherever deemed necessary. The biostatical analysis was performed using program IBM SPSS (Statistical Package for the Social Sciences), for quantitative data student’s t- test was applied. P value was considered statistically significant if P < 0.05, and highly statistically significant if P < 0.01. Result: A total of 158 cases were of neoplasia cervix. Majority of cases were squamous cell carcinoma type, i.e., 96.6% (174 cases) followed by adenocarcinoma constituting only 2.8% (5 cases) with a mean age of 50 years and average gravida of 3.78. Majority of cases (50.01%) complained of postmenopausal bleeding followed by abnormal spotting (26.67%) and lower abdominal pain (7.78%). The most common presentation was in Stage IIB with 45.56% (82) cases. Conclusion: Histomorphology remains the mainstay of diagnosis of cervical cancers. In low compliance settings such as ours, colposcopy‑guided biopsy is the preferred course of management, especially in elderly females to be definite to rule out or diagnose neoplasia. National level cervical cancer program is immediate need of the hour and should include human papilloma virus vaccine, awareness, and screening programs as well as treatment assistance for low socioeconomic strata.